3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerIntermediate Risk Non-Muscle Invasive Bladder CancerRecruitingPhase 32026-10-07NCT06510374
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder Cancer With Carcinoma in SituRecruitingPhase 32026-09-25NCT06545955
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal PelvisLow-grade Upper Tract Urothelial CarcinomaRecruitingPhase 1 / Phase 22026-09-15NCT06668493